ResMed | 营业费用



金融业
股票价格
USD
资产
USD 8.5B
现金及等价物
USD 1.42B
销售成本
USD 555.85M
流动资产
USD 3.82B
流动负债
USD 1.25B
债务
USD 846.35M
股息收益率
0.94
EBIT
USD 497.6M
EBITDA
USD 547.48M
员工
10.6K
EPS每股收益
USD 2.81
股本和储备
USD 6.32B
销售毛利
USD 878.72M
债务利息支出
USD 8.79M
利息收入
USD 59K
贷款资金
USD 403.92M
市值
USD 38.11B
净收入
USD 392.59M
营业费用
USD 925.21M
营业利润
USD 497.6M
普通股股本
USD 145.97M
PE价格收益
USD 23.36
税前利润
USD 482.38M
销售收入
USD 1.4B
销售和管理费用
USD 278.4M
股票
USD 922.05M
贸易债权人
USD 250.41M
应收帐款人
USD 985.63M


营业费用 更改 日
Ansell USD 414.45M 55.9M 2025-06
Artivion USD 56.62M 195K 2024-09
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Cochlear AUD 460.1M 437.1M 2025-06
Cooper Companies USD 924.8M 40.2M 2025-09
CSL USD 2.87B 2.85B 2025-06
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Fisher Paykel Healthcare NZD 802.4M 24.1M 2025-12
Globus Medical USD 886.57M 730.06M 2025-09
Haemonetics USD 134.99M 1.26M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Idexx Laboratories USD 774.97M 24.58M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 1.04B 620.66M 2025-09
Intuitive Surgical USD 2B 263.6M 2025-12
Masimo USD 147M 159.4M 2025-09
Medtronic USD 7.28B 16M 2025-12
Philips EUR 4.38B 405M 2025-12
Ramsay Health Care AUD 8.72B 369.4M 2025-06
ResMed USD 925.21M 51.98M 2025-12
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.22B 28.8M 2025-12
Teleflex USD 3.82B 3.22B 2025-09
Thermo Fisher Scientific USD 9.91B 867M 2025-12


ResMed 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.